Europe human leukocyte antigen (HLA) typing for transplant market is growing with a CAGR of 7.8% in the forecast period of 2021 to 2028 and is expected to reach USD 344.87 million by 2028
Europe Human Leukocyte Antigen (HLA) Typing for Transplant Market, By Products and Services (Reagents and Consumables, Instruments, Software and Services), Technology (Sequencing- Based Molecular Assays, Molecular Assay Technologies, Non- Molecular Assay Technologies), Transplant Type (Solid Organ Transplant, Haematopoietic Stem Cell Transplant), Application (Diagnostic Applications, Research Application), End User (Independent Reference Laboratories, Hospitals and Transplant Centres, Research Laboratories and Academic Institutes), Country (U.K., France, Italy, Spain, Switzerland, Russia, Netherlands, Turkey, Belgium, and Rest of Europe) Industry Trends and Forecast to 2028.
Market Analysis and Insights: Europe Human Leukocyte Antigen (HLA) Typing for Transplant Market
· Europe human leukocyte antigen (HLA) typing for transplant market is expected to gain significant growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the Europe human leukocyte antigen (HLA) typing for transplant market is growing with a CAGR of 7.8% in the forecast period of 2021 to 2028 and is expected to reach USD 344.87 million by 2028 from USD 194.35 million in 2020. Rising demand for organ transplant procedures is acting as driver for the growth of global human leukocyte typing for transplant market.
Europe Human Leukocyte Antigen (HLA) Typing for Transplant Market and Market Size
· On the basis of by products and services, Europe human leukocyte antigen (HLA) typing for transplant market is segmented in reagents and consumables, instruments, software and services. In 2021, instruments segment is expected to dominate the market due to high demand for organ transplantation that has rapidly increased.
· On the basis of technology, Europe human leukocyte antigen (HLA) typing for transplant market is molecular assay technologies and non- molecular assay technologies. In 2021, molecular assay technologies segment is expected to dominate the market due to rising awareness about the disease.
· On the basis of transplant type, Europe human leukocyte antigen (HLA) typing for transplant market is segmented solid organ transplant and haematopoietic stem cell transplant. In 2021, solid organ transplant segment is expected to dominate the market because of increasing prevalence of this disease type among target population.
· On the basis of application, the Europe human leukocyte antigen (HLA) typing for transplant market is segmented into diagnostic applications and research application. In 2021, diagnostic applications segment is expected to dominate the market because of high pool of patients with cancer and genetic diseases.
· On the basis of end user, the Europe human leukocyte antigen (HLA) typing for transplant market is segmented into independent reference laboratories, hospitals and transplant centres, research laboratories and academic institutes. In 2021, hospitals & transplant centers segment is expected to dominate the market owing to the rising product launches by the key market players.
Get the sample copy of Report here: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=europe-hla-typing-transplant-market
Europe Human Leukocyte Antigen (HLA) Typing for Transplant Market Country Level Analysis
· Countries covered in the Europe human leukocyte antigen (HLA) typing for transplant market report are Germany, France, U.K., Hungary, Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, and rest of Europe.
Competitive Landscape and Europe Human Leukocyte Antigen (HLA) Typing for Transplant Market Share Analysis
· Europe human leukocyte antigen (HLA) typing for transplant market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, and technology lifeline curve. The above data points provided are only related to the companies’ focus related to Europe human leukocyte antigen (HLA) typing for transplant market.
Major players covered in the report are
· Thermo Fisher Scientific Inc.,
· Illumina, Inc.,
· Luminex Corporation,
· QIAGEN,
· CareDX, Inc.,
· Immucor Inc.,
· Bio Rad Labaratories, Inc.,
· Takara Bio Inc.,
· BD, Fujirebio,
· TBG Diagnostics Limited,
· GenDx.
Full Access of Report @ https://www.databridgemarketresearch.com/reports/europe-hla-typing-transplant-market
MAJOR TOC OF THE REPORT
· INTRODUCTION
· MARKET SEGMENTATION
· EXECUTIVE SUMMARY
· PREMIUM INSIGHTS
· MARKET OVERVIEW
· QUESTIONNAIRE
RELATED REPORTS
Get TOC Details
https://www.databridgemarketresearch.com/toc/?dbmr=europe-hla-typing-transplant-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
Browse Related Reports@
